NCT02264613 2026-01-13ALRN-6924 in Patients With Advanced Solid Tumors or LymphomasAileron Therapeutics, Inc.Phase 1/2 Completed142 enrolled 30 charts
NCT04105010 2025-04-04Assessing An Oral Janus Kinase Inhibitor, AZD4205 as Monotherapy in Patients Who Have PTCL (JACKPOT8)Dizal PharmaceuticalsPhase 1/2 Completed171 enrolled 23 charts
NCT00888927 2024-04-25Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell LymphomaKyowa Kirin Co., Ltd.Phase 1/2 Completed42 enrolled 13 charts
NCT02440685 2023-06-07A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsAsana BioSciencesPhase 1/2 Terminated51 enrolled 18 charts
NCT01075321 2020-10-22Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin LymphomaMayo ClinicPhase 1/2 Completed58 enrolled 12 charts
NCT01456039 2019-02-11A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)CelgenePhase 1/2 Completed51 enrolled 34 charts
NCT00787527 2014-09-09SAHA + CHOP in Untreated T-cell Non-Hodgkin's LymphomaM.D. Anderson Cancer CenterPhase 1/2 Completed14 enrolled 8 charts